BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 31190982)

  • 1. The utility of folate receptor-positive circulating tumor cell in cancer diagnosis in the elderly population.
    Li N; Zhong D; Chen H; Huang T; Hou P; Zhang Y; Chen F; Wang X; Zhang H
    Cancer Manag Res; 2019; 11():4097-4107. PubMed ID: 31190982
    [No Abstract]   [Full Text] [Related]  

  • 2. Validation of the diagnostic efficiency of folate receptor-positive circulating tumor cells in lung cancers: a prospective observational study.
    Liu J; Han M; Huang H
    Transl Cancer Res; 2019 Aug; 8(4):1242-1248. PubMed ID: 35116866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folate-receptor-positive circulating tumor cells as an efficacious biomarker for the diagnosis of small pulmonary nodules.
    Xue Y; Cong W; Xie S; Shu J; Feng G; Gao H
    J Cancer Res Ther; 2018; 14(7):1620-1626. PubMed ID: 30589049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of folate receptor-positive circulating tumor cells in the diagnosis of lung cancer and its correlation with clinical characteristics.
    Xu Y; Li Q; Lin Z; Lin Y
    Clin Respir J; 2023 May; 17(5):374-383. PubMed ID: 36977421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The combination of folate receptor-positive circulating tumor cells and serum tumor markers suggests a histological diagnosis of lung cancer.
    Lv X; Wu S; Xu X; Wu L; Chang N; Zhang J; Ti X
    J Thorac Dis; 2022 Jan; 14(1):158-168. PubMed ID: 35242377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of colorectal cancer based on folate receptor-positive circulating tumor cell analysis: a retrospective cohort study.
    Wei ZJ; Zhou BC; Wang GX; Han WX; Li YX; Xu AM
    Int J Clin Oncol; 2024 Feb; 29(2):149-158. PubMed ID: 38112831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A preliminary study of the clinical significance of folate receptor-positive circulating tumor cell in the management of hepatobiliary-pancreatic cancers.
    He YG; Zheng L; Gao MF; Tang YC; Li YM; Yu KH; Li J; Huang XB
    Transl Cancer Res; 2020 Nov; 9(11):6700-6709. PubMed ID: 35117280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Significance of Folate Receptor-positive Circulating Tumor Cells Detected by Ligand-targeted Polymerase Chain Reaction in Lung Cancer.
    Wang L; Wu C; Qiao L; Yu W; Guo Q; Zhao M; Yang G; Zhao H; Lou J
    J Cancer; 2017; 8(1):104-110. PubMed ID: 28123603
    [No Abstract]   [Full Text] [Related]  

  • 9. Detection of folate receptor-positive circulating tumor cells as a biomarker for diagnosis, prognostication, and therapeutic monitoring in breast cancer.
    Wu Q; Zheng H; Gu J; Cheng Y; Qiao B; Wang J; Xiong L; Sun S; Wu Z; Bao A; Tong Y
    J Clin Lab Anal; 2022 Jan; 36(1):e24180. PubMed ID: 34919735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folate receptor-positive circulating tumor cells in predicting ground-glass nodules malignancy.
    Yue YS; Sun ZH; Cui Q; Jiang GZ
    Am J Transl Res; 2023; 15(4):2828-2835. PubMed ID: 37193191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folate receptor-positive circulating tumor cell count, lymphocyte count and derived neutrophil-to- lymphocyte ratio for diagnosing lung cancer relapse.
    Wang H; Liu L; Yan J; Ma W; Du Y; Zhang T
    Front Oncol; 2022; 12():1097816. PubMed ID: 36741689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative Folate Receptor-Positive Circulating Tumor Cell Level Is a Prognostic Factor of Long Term Outcome in Non-Small Cell Lung Cancer Patients.
    Li H; Li B; Pan Y; Zhang Y; Xiang J; Zhang Y; Sun Y; Yu X; He W; Hu H
    Front Oncol; 2020; 10():621435. PubMed ID: 33585249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of folate receptor-positive circulating tumour cells in the clinical management of indeterminate lung nodules: A non-invasive biomarker for predicting malignancy and tumour invasiveness.
    Zhou Q; Geng Q; Wang L; Huang J; Liao M; Li Y; Ding Z; Yang S; Zhao H; Shen Q; Pan C; Lou J; Lu S; Chen C; Luo Q
    EBioMedicine; 2019 Mar; 41():236-243. PubMed ID: 30872130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of colorectal cancer liver metastases based on liquid biopsy combined with folate receptor- Positive circulating tumor cells and HSP90.
    Huang M; Cheng L; Mo S; Ru H; Mo X; Yan L
    Front Oncol; 2022; 12():912016. PubMed ID: 36203415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of folate receptor-positive circulating tumor cell analysis in the diagnosis of colorectal cancer: a retrospective cohort study.
    Yan S; Guo W; Liu Y; Li K; Wang W
    Int J Clin Oncol; 2022 Mar; 27(3):538-544. PubMed ID: 35043284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative Folate Receptor-Positive Circulating Tumor Cells Are Associated With Occult Peritoneal Metastasis and Early Recurrence in Gastric Cancer Patients: A Prospective Cohort Study.
    Zeng CDD; Jin CC; Gao C; Xiao AT; Tong YX; Zhang S
    Front Oncol; 2022; 12():769203. PubMed ID: 35425708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A retrospective diagnostic test study on circulating tumor cells and artificial intelligence imaging in patients with lung adenocarcinoma.
    Ma M; Xu S; Han B; He H; Ma X; Chen C
    Ann Transl Med; 2022 Dec; 10(24):1339. PubMed ID: 36660706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative levels of folate receptor-positive circulating tumor cells in different subtypes of early-stage lung adenocarcinoma: Predictive value for determining extent of surgical resection.
    Zhou C; Zhao R; Zhao R; Wang A; Li W
    Front Oncol; 2023; 13():1119807. PubMed ID: 37139152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folate receptor-positive circulating tumor cells in the preoperative diagnosis of indeterminate pulmonary nodules.
    Li Z; Cai J; Zhao Y; Cai J; Zhao X
    J Clin Lab Anal; 2022 Oct; 36(10):e24654. PubMed ID: 36217263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folate receptor-positive circulating tumor cells as a novel diagnostic biomarker in non-small cell lung cancer.
    Yu Y; Chen Z; Dong J; Wei P; Hu R; Zhou C; Sun N; Luo M; Yang W; Yao R; Gao Y; Li J; Yang G; He W; He J
    Transl Oncol; 2013 Dec; 6(6):697-702. PubMed ID: 24466372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.